As a core regulator of metabolic diseases and their complications, PKCβ is specifically induced to be expressed in white adipose tissue (WAT) under a high‐fat diet, leading to obesity, insulin resistance, and fatty liver by disrupting mitochondrial function and regulating the p66Shc signaling pathway [63]. Here, PRKCB is linked to metabolic disease.